Answers are grounded in this paper and cite their sources.
Background. Combined influenza/COVID-19 outpatient clinics generate large volumes of respiratory swab data that can inform local pathogen surveillance. We described the burden, distribution, and temporal trend of respiratory viral detections in such a clinic over four consecutive months. Methods. We conducted a retrospective cross-sectional analysis of 1381 respiratory swab episodes recorded between January and April. Swabs were tested by rapid antigen assay, RT-PCR, or both, for SARS-CoV-2, influenza A, influenza B and RSV. Positivity was summarized with 95% Wilson confidence intervals (CI); associations were assessed using the χ2 and Fisher exact tests, and the monthly trend with the Cochran–Armitage test. Results. Overall positivity was 7.1% (95% CI 5.9–8.6). SARS-CoV-2 was the predominant pathogen (62/98; 63.3% of positives), followed by RSV (19), influenza A (12) and influenza B (5). Positivity rose significantly from 4.1% in January to 9.5% in April (χ2 = 11.46, p = 0.009; trend p = 0.011), driven by an April COVID-19 surge. Positivity was similar between sexes (p = 0.456) but higher when reflex RT-PCR accompanied the rapid test (10.9% vs 5.6%; p = 0.001). Conclusions. In this outpatient setting, SARS-CoV-2 dominated respiratory viral detections and rose sharply over the study period, while influenza and RSV were comparatively infrequent. The findings support continued integrated, multi-pathogen point-of-care surveillance with selective molecular confirmation.
No takes yet. Share an insight, caveat, or question.
Nadeem et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: